Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions

Bladder cancer is the most common malignant tumor of urinary system worldwide. Approximately 75% of patients with bladder cancer present with non-muscle-invasive bladder cancer (NMIBC), which is effectively managed with transurethral resection of bladder tumor (TURBT). For refractory high risk NMIBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xinghui, Dai, Tianzeng, Xu, Lihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130525/
https://www.ncbi.nlm.nih.gov/pubmed/37123545
http://dx.doi.org/10.3389/fsurg.2023.1143219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130525/
https://www.ncbi.nlm.nih.gov/pubmed/37123545
http://dx.doi.org/10.3389/fsurg.2023.1143219

Ejemplares similares